Effects of surfactants on the crystallization and polymorphism of lipid nanoparticles

  • Heike BunjesEmail author
  • Michel H. J. Koch
  • Kirsten Westesen
Conference paper
Part of the Progress in Colloid and Polymer Science book series (PROGCOLLOID, volume 121)


Colloidal dispersions of solid triglycerides as potential drug carriers are preferably prepared by high-pressure homogenization of molten triglycerides in an aqueous phase with adequate stabilizers and subsequent crystallization of the emulsified lipid particles. The influence of several commercial ionic and nonionic stabilizers and their blends with phosholipid on the crystallization and subsequent polymorphic transitions of tripalmitin nanoparticles was investigated. The stabilizers differed, for example, in the hydrophilic head group and the length and degree of saturation of the hydrophobic chains. Besides macroscopic effects in some of the systems, the stabilizers had pronounced effects on crystallization and polymorphic transitions. There was a clear lower limit for the critical crystallization temperature in agreement with the theory of homogenous nucleation. For some of the dispersions, the appearance of X-ray reflections and thermal events suggested that interactions with the stabilizer layer induced crystallization of the triglyceride at higher temperatures. The transformation of the nanoparticles from the metastable α polymorph to the stable β polymorph proceeded at different rates for the different types of stabilizers and was in most cases not quantitative within the time scale of the X-ray experiments. A complex X-ray diffraction pattern for some of the dispersions complicated the direct comparison of the transition processes. The presence of ionic surfactants often led to a slower transformation than stabilization with nonionic surfactants and their blends with phospholipids.

Key words

Lipid nanoparticles Triglycerides Crystallization Polymorphism 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Westesen K, Siekmann B (1996) In: Benita S (ed) Microencapsulation. Dekker, New York, pp 213–258Google Scholar
  2. 2.
    Mehnert W, Mäder K (2001) Adv Drug Delivery Rev 47:165CrossRefGoogle Scholar
  3. 3.
    Bunjes H, Koch MHJ, Westesen K (1999) Arch Pharm Pharm Med Chem 332(Suppl 2):7Google Scholar
  4. 4.
    Bunjes H, Westesen K (2001) In: Garti N, Sato K (eds) Crystallization processes in fats and lipid systems. Dekker, New York, pp 457–483Google Scholar
  5. 5.
    Dickinson E, McClements DJ (1995) In: Dickinson E, McClements DJ (eds) Advances in food colloids. Chapman and Hall, Glasgow, pp 211–246Google Scholar
  6. 6.
    Bunjes H, Koch MHJ, Westesen K (2000) Langmuir 16:5234–5241CrossRefGoogle Scholar
  7. 7.
    Bunjes H, Westesen K, Koch MHJ (1996) Int J Pharm 129:159CrossRefGoogle Scholar
  8. 8.
    Mehlem J, Unruh T, Westesen K (2000) Proceedings of the international symposium on controlled release of bioactive materials 27, No. 8128Google Scholar

Copyright information

© Springer-Verlag 2002

Authors and Affiliations

  • Heike Bunjes
    • 1
    Email author
  • Michel H. J. Koch
    • 2
  • Kirsten Westesen
    • 1
  1. 1.Institute of Pharmacy, Department of Pharmaceutical TechnologyFriedrich-Schiller-Universität JenaJenaGermany
  2. 2.European Molecular Biology LaboratoryHamburg Outstation, EMBL c/o DESYHamburgGermany

Personalised recommendations